Vanguard Group’s Humacyte HUMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.6M | Buy |
6,999,624
+399,978
| +6% | +$836K | ﹤0.01% | 2710 |
|
|
2025
Q1 | $11.3M | Buy |
6,599,646
+996,962
| +18% | +$1.7M | ﹤0.01% | 2779 |
|
|
2024
Q4 | $28.3M | Buy |
5,602,684
+543,995
| +11% | +$2.75M | ﹤0.01% | 2417 |
|
|
2024
Q3 | $27.5M | Buy |
5,058,689
+329,095
| +7% | +$1.79M | ﹤0.01% | 2441 |
|
|
2024
Q2 | $22.7M | Buy |
4,729,594
+709,913
| +18% | +$3.41M | ﹤0.01% | 2508 |
|
|
2024
Q1 | $12.5M | Buy |
4,019,681
+896,415
| +29% | +$2.79M | ﹤0.01% | 2840 |
|
|
2023
Q4 | $8.87M | Buy |
3,123,266
+104,299
| +3% | +$296K | ﹤0.01% | 3016 |
|
|
2023
Q3 | $8.85M | Buy |
3,018,967
+50,331
| +2% | +$147K | ﹤0.01% | 2950 |
|
|
2023
Q2 | $8.49M | Buy |
2,968,636
+2,359
| +0.1% | +$6.75K | ﹤0.01% | 3040 |
|
|
2023
Q1 | $9.17M | Buy |
2,966,277
+121,014
| +4% | +$374K | ﹤0.01% | 2983 |
|
|
2022
Q4 | $6M | Buy |
2,845,263
+174,140
| +7% | +$367K | ﹤0.01% | 3216 |
|
|
2022
Q3 | $8.71M | Sell |
2,671,123
-2,882
| -0.1% | -$9.39K | ﹤0.01% | 3015 |
|
|
2022
Q2 | $8.58M | Buy |
2,674,005
+251,985
| +10% | +$809K | ﹤0.01% | 3075 |
|
|
2022
Q1 | $17.1M | Buy |
2,422,020
+1,253,788
| +107% | +$8.85M | ﹤0.01% | 2859 |
|
|
2021
Q4 | $8.47M | Buy |
1,168,232
+878,123
| +303% | +$6.37M | ﹤0.01% | 3311 |
|
|
2021
Q3 | $3.37M | Buy |
+290,109
| New | +$3.37M | ﹤0.01% | 3869 |
|